OnabotulinumtoxinaA para Platysma Prominence: Safety and Eficacy Results from a Phase 3 Open-Label Repeat Treatment Study
CirurgiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Plastic and reconstructive surgery
- Publicado em
- 4 dez 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study
Deanne Mraz, C. William Hanke, Ira D. Papel, Kenneth Robert Beer, Steven G Yoelin, Susan H. Weinkle, Terrence Colin Keaney, Rodney J. Rohrich, R. Mccaskill, Sandhya V. Shimoga et al.
Descritores MeSH
- Superficial Musculoaponeurotic System
- Neuromuscular Agents
- Skin Aging
- Botulinum Toxins, Type A
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Treatment Outcome
- Retreatment
Veja também
Estudos relacionados
- IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From Two Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
- Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Platysma Prominence: A Randomized Phase 2 Dose-Ranging Study
- Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial
- A Controlled Phase 2b Trial to Assess the Efficacy and Safety of a Single Intervention of OnabotulinumtoxinA for Treating Masseter Muscle Prominence
- Improving Neck and Jawline Aesthetics With OnabotulinumtoxinA by Minimizing Platysma Muscle Contraction Effects: Efficacy and Safety Results in a Phase 3 Randomized, Placebo-Controlled Study
- Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial